A detailed history of Nicholas Company, Inc. transactions in Dexcom Inc stock. As of the latest transaction made, Nicholas Company, Inc. holds 767,716 shares of DXCM stock, worth $87.3 Million. This represents 1.8% of its overall portfolio holdings.

Number of Shares
767,716
Previous 842,311 8.86%
Holding current value
$87.3 Million
Previous $105 Million 1.88%
% of portfolio
1.8%
Previous 1.88%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$114.22 - $140.1 $8.52 Million - $10.5 Million
-74,595 Reduced 8.86%
767,716 $106 Million
Q4 2023

Feb 13, 2024

BUY
$75.49 - $124.16 $5.11 Million - $8.41 Million
67,751 Added 8.75%
842,311 $105 Million
Q3 2023

Feb 13, 2024

BUY
$86.06 - $137.93 $23.7 Million - $38 Million
275,515 Added 55.21%
774,560 $72.3 Million
Q3 2023

Nov 13, 2023

BUY
$86.06 - $137.93 $23.7 Million - $38 Million
275,515 Added 55.21%
774,560 $72.3 Million
Q4 2022

Feb 13, 2024

SELL
$84.98 - $122.67 $11,472 - $16,560
-135 Reduced 0.03%
499,045 $56.5 Million
Q4 2022

Feb 09, 2023

SELL
$84.98 - $122.67 $11,472 - $16,560
-135 Reduced 0.03%
499,045 $56.5 Million
Q3 2022

Feb 13, 2024

BUY
$76.35 - $94.18 $3.08 Million - $3.79 Million
40,280 Added 8.78%
499,180 $40.2 Million
Q3 2022

Nov 14, 2022

BUY
$76.35 - $94.18 $3.08 Million - $3.79 Million
40,280 Added 8.78%
499,180 $40.2 Million
Q2 2022

Feb 13, 2024

BUY
$67.99 - $132.89 $24.4 Million - $47.7 Million
358,595 Added 357.5%
458,900 $34.2 Million
Q2 2022

Jul 26, 2022

BUY
$67.99 - $132.89 $24.4 Million - $47.7 Million
358,595 Added 357.5%
458,900 $34.2 Million
Q1 2022

Feb 13, 2024

SELL
$94.08 - $130.2 $63.4 Million - $87.8 Million
-674,255 Reduced 87.05%
100,305 $12.8 Million
Q1 2022

May 11, 2022

SELL
$94.08 - $130.2 $1,881 - $2,604
-20 Reduced 0.02%
100,305 $51.3 Million
Q4 2021

Feb 11, 2022

SELL
$129.87 - $162.82 $12,987 - $16,282
-100 Reduced 0.1%
100,325 $53.9 Million
Q3 2021

Nov 15, 2021

SELL
$106.71 - $143.18 $1,067 - $1,431
-10 Reduced 0.01%
100,425 $54.9 Million
Q2 2021

Aug 12, 2021

BUY
$80.99 - $107.93 $1.22 Million - $1.62 Million
15,055 Added 17.63%
100,435 $42.9 Million
Q1 2021

May 14, 2021

SELL
$84.79 - $104.74 $33,916 - $41,896
-400 Reduced 0.47%
85,380 $30.7 Million
Q4 2020

Feb 10, 2021

BUY
$78.0 - $104.5 $6.69 Million - $8.96 Million
85,780 New
85,780 $31.7 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $43.9B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Nicholas Company, Inc. Portfolio

Follow Nicholas Company, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nicholas Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Nicholas Company, Inc. with notifications on news.